指南与共识胸部肿瘤

中国肺癌筛查与早诊早治指南(2021,北京)

[China guideline for the screening and early detection of lung cancer(2021, Beijing)].
指南 / 共识 · Zhonghua Zhong Liu Za Zhi · 2021-01-01

肺癌是中国发病率和死亡率最高的恶性肿瘤,筛查与早诊早治是降低人群肺癌死亡率的有效措施。该指南受国家卫生健康委员会疾病预防控制局委托与指导,由国家癌症中心发起,联合多学科专家共同制定,整合国内外肺癌筛查与早诊早治新进展并考虑中国国情和实际经验。指南针对筛查人群、技术、流程等给出详细循证推荐,旨在规范肺癌筛查与早诊早治实践,提升中国肺癌防控效果。

要点

  • 肺癌是中国发病率和死亡率最高的恶性肿瘤。
  • 筛查与早诊早治是降低人群肺癌死亡率的有效措施。
  • 指南针对筛查人群、技术、流程等给出详细循证推荐。

核心结论

  • 制定符合中国国情的肺癌筛查与早诊早治指南可推进筛查同质性和优质性并提高筛查效果。

研究设计与样本

  • 指南受国家卫生健康委员会疾病预防控制局委托与指导,由国家癌症中心发起,联合多学科专家共同制定。
  • 指南根据世界卫生组织指南制定手册的原则和方法制定。

关键数值与推荐

  • 指南针对肺癌筛查过程中的筛查人群、技术、流程等给出了详细的循证推荐。

临床怎么用

  • 指南旨在规范肺癌筛查与早诊早治实践,提升中国肺癌防控效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In China, the malignant tumor with the highest incidence and motality is lung cancer (LC). As screening and early detection and treatment are effective in reducing LC mortality, formulating a guideline in line with China's national conditions for the screening and early detection and treatment of LC will greatly promote the homogeneity and accuracy of LC screening, and result in an improvement of the effectiveness of LC screening. Commissioned and directed by the Disease Prevention and Control Bureau of the National Health Commission of the People's Republic of China, the guidline was initiated by the National Cancer Center of China and formulated with joint effort by experts from different disciplines. Following the principles and methods in WHO Handbook for Guideline Development, the guidline integrates the latest development in LC screening and early diagnosis and treatment worldwide while fully considering China's national conditions and practical experience in LC screening. It provides detailed evidence-based recommendations for different aspects of LC screening, such as the targeted population, the technologies and the procedures, to regulate the practices of LC screening and early diagnosis and treatment and enhance the effectiveness of the prevention and control of LC in China. 肺癌是中国发病率和死亡率最高的恶性肿瘤。筛查与早诊早治是降低人群肺癌死亡率的有效措施。制定符合中国国情的肺癌筛查与早诊早治指南,将极大推进中国肺癌筛查的同质性和优质性,提高肺癌筛查的效果。指南受国家卫生健康委员会疾病预防控制局委托与指导,由国家癌症中心发起,联合多学科专家共同制定。指南整合近年来国内外在肺癌筛查与早诊早治方面的新进展,同时考虑中国国情和肺癌筛查的实际经验,根据世界卫生组织指南制定手册的原则和方法,针对肺癌筛查过程中的筛查人群、技术、流程等给出了详细的循证推荐,旨在规范肺癌筛查与早诊早治实践,提升中国肺癌防控效果。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. He J, Li N, Chen WQ, et al. [China guideline for the screening and early detection of lung cancer(2021, Beijing)]. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 33752304. doi:10.3760/cma.j.cn112152-20210119-00060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。